Tech Company Financing Transactions
COMPASS Pathways Funding Round
COMPASS Pathways secured a $285 million financing round on 8/18/2023. Backers included Aisling Capital, Armistice Capital and Laurion Capital Management.
Transaction Overview
Company Name
Announced On
8/18/2023
Transaction Type
Venture Equity
Amount
$285,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The transaction is being conducted by a consortium of healthcare specialist investors and the net proceeds of the sale are expected to extend COMPASS Pathway's runway well into 2025.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3rd Floor, 1 Ashley Road Cheshire
Altrincham, England, WA14 2DT
UK
Altrincham, England, WA14 2DT
UK
Phone
Undisclosed
Website
Email Address
Overview
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 8/18/2023: Arpio venture capital transaction
Next: 8/18/2023: Lore venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs